The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Half-Life

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Half-Life.
Olatoyosi Odenike
Connection Strength
0.019
Half-Life
  1. A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia. Invest New Drugs. 2008 Aug; 26(4):331-8.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.